Advances in Key Drug Target Identification and New Drug Development for Tuberculosis

被引：27

作者：

Mi, Jie ^{[1
]}

Gong, Wenping ^{[1
]}

Wu, Xueqiong ^{[1
]}

机构：

[1] Peoples Liberat Army Gen Hosp, Med Ctr 8, Senior Dept TB, Beijing Key Lab New Tech TB Diag & Treatment,TB P, Beijing 100091, Peoples R China

来源：

BIOMED RESEARCH INTERNATIONAL | 2022年 / 2022卷

关键词：

PROTEIN-TYROSINE-PHOSPHATASE; MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; POTENT INHIBITORS; IN-VITRO; BACTERICIDAL ACTIVITY; ANTIBACTERIAL AGENTS; MALARIA PARASITES; ISOCITRATE LYASE; SYNTHASE III;

D O I：

10.1155/2022/5099312

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Tuberculosis (TB) is a severe infectious disease worldwide. The increasing emergence of drug-resistant Mycobacterium tuberculosis (Mtb) has markedly hampered TB control. Therefore, there is an urgent need to develop new anti-TB drugs to treat drug-resistant TB and shorten the standard therapy. The discovery of targets of drug action will lay a theoretical foundation for new drug development. With the development of molecular biology and the success of Mtb genome sequencing, great progress has been made in the discovery of new targets and their relevant inhibitors. In this review, we summarized 45 important drug targets and 15 new drugs that are currently being tested in clinical stages and several prospective molecules that are still at the level of preclinical studies. A comprehensive understanding of the drug targets of Mtb can provide extensive insights into the development of safer and more efficient drugs and may contribute new ideas for TB control and treatment.

引用

页数：23

共 178 条

[1] Activity of the Fluoroquinolone DC-159a in the Initial and Continuation Phases of Treatment of Murine Tuberculosis [J].

Ahmad, Zahoor ;

Minkowski, Austin ;

Peloquin, Charles A. ;

Williams, Kathy N. ;

Mdluli, Khisimuzi E. ;

Grosset, Jacques H. ;

Nuermberger, Eric L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) :1781-1783

[2] Identifying the analogues of berberine as promising antitubercular drugs targeting Mtb-FtsZ polymerisation through ligand-based virtual screening and molecular dynamics simulations [J].

Akinpelu, Olayinka, I ;

Kumalo, Hezekiel M. ;

Mhlongo, Sizwe, I ;

Mhlongo, Ndumiso N. .

JOURNAL OF MOLECULAR RECOGNITION, 2022, 35 (02)

[3] Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity [J].

Akopian, Tatos ;

Kandror, Olga ;

Tsu, Christopher ;

Lai, Jack H. ;

Wu, Wengen ;

Liu, Yuxin ;

Zhao, Peng ;

Park, Annie ;

Wolf, Lisa ;

Dick, Lawrence R. ;

Rubin, Eric J. ;

Bachovchin, William ;

Goldberg, Alfred L. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (17) :11008-11020

[4] Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria [J].

Alahari, Anuradha ;

Trivelli, Xavier ;

Guerardel, Yann ;

Dover, Lynn G. ;

Besra, Gurdyal S. ;

Sacchettini, James C. ;

Reynolds, Robert C. ;

Coxon, Geoffrey D. ;

Kremer, Laurent .

PLOS ONE, 2007, 2 (12)

[5]

Alliance T.B., 2018, PHASE 1 CLIN TRIAL T

[6] Novel compounds targeting InhA for TB therapy [J].

AlMatara, Manaf ;

Makky, Essam A. ;

Var, Isil ;

Kayar, Begum ;

Koksal, Fatih .

PHARMACOLOGICAL REPORTS, 2018, 70 (02) :217-226

[7] Identification of New Mycobacterium tuberculosis Proteasome Inhibitors Using a Knowledge-Based Computational Screening Approach [J].

Almeleebia, Tahani M. ;

Al Shahrani, Mesfer ;

Alshahrani, Mohammad Y. ;

Ahmad, Irfan ;

Alkahtani, Abdullah M. ;

Alam, Md Jahoor ;

Kausar, Mohd Adnan ;

Saeed, Amir ;

Saeed, Mohd ;

Iram, Sana .

MOLECULES, 2021, 26 (08)

[8] Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies [J].

Amaral, L ;

Kristiansen, JE .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) :173-176

[9] Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) [J].

Anh Thu Tran ;

Wen, Daying ;

West, Nicholas P. ;

Baker, Edward N. ;

Britton, Warwick J. ;

Payne, Richard J. .

ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (46) :8113-8126

[10] Identification of the INO1 gene of Mycobacterium tuberculosis H37Rv reveals a novel class of inositol-1-phosphate synthase enzyme [J].

Bachhawat, N ;

Mande, SC .

JOURNAL OF MOLECULAR BIOLOGY, 1999, 291 (03) :531-536

← 1 2 3 4 5 6 7 8 9 10 →